Skip to main content

Table 1 Baseline characteristic of eligible case-control studies

From: Association between GABRG2 rs211037 polymorphism and idiopathic generalized epilepsies: a meta-analysis

Author

Year

Country

Ethnity

Type of epilepsy

Genotyping Methods

Control

Total

Case

Control

Abou [9]

2018

Egypt

Asian

IGE

PCR-RFLP

healthy

210

100

110

Balan [10]

2013

India

Asian

JME

AS-PCR

healthy

500

235

265

Bhat [11]

2018

India

Asian

JME

PCR-RFLP

healthy

150

50

100

Butila [12]

2018

Romania

Caucasians

IGE

PCR-RFLP

patients

213

60

153

Chou [13]

2007

China

Asian

IGE

PCR-RFLP

healthy

160

77

83

Gitai [14]

2012

Brazil

Mixed

JME

PCR-RFLP

healthy

228

98

130

Haerian [15]

2015

Malaysia

Asian

IGE

MassARRAY

healthy

1,254

176

1,078

Kananura [16]

2002

Germany

Caucasian

CAE

RT-PCR

healthy

289

135

154

Kim [17]

2012

Korean

Asian

CAE

PCR

healthy

242

35

207

Kinirons A [18]

2006

UK

NA

IGE

tSNP

healthy

408

78

330

Kinirons B [18]

2006

Ireland

NA

IGE

tSNP

healthy

400

117

283

Ponnala [19]

2012

India

Asian

IGE

PCR-RFLP

healthy or patients

186

86

100

  1. AS-PCR Allele-specific polymerase chain reaction, CAE childhood absence epilepsy, IGE childhood idiopathic generalized epilepsy, JME Juvenile myoclonic epilepsy, MassARRAY matrixassisted laser desorption/ionization time of flight mass spectrometry, NA not available, PCR-RFLP polymerase chain reaction-restriction fragment length polymorphism, RT-PCR reverse transcription- polymerase chain reaction, tSNP a tagging single nucleotide polymorphism